Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Breast 2

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1

Interventions

Fulvestrant 85Letrozole 79Paclitaxel 76pembrolizumab 72Specimen Handling 65Trastuzumab 62Carboplatin 56Magnetic Resonance Spectroscopy 52ribociclib 49Capecitabine 49Anastrozole 48pertuzumab 46palbociclib 45exemestane 40Tamoxifen 40Cyclophosphamide 40abemaciclib 39Biopsy 38trastuzumab deruxtecan 31Docetaxel 30Taxes 27Radiotherapy 27Gemcitabine 25Blood Specimen Collection 25130-nm albumin-bound paclitaxel 24Surveys and Questionnaires 23Standard of Care 22olaparib 21sacituzumab govitecan 20eribulin 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Biosimilar Pharmaceuticals × Breast × 90 days × Clear all
NCT07220135 2026-05-06

NeoTHERa

University of Kansas Medical Center

Phase 2 Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT06649331 2026-04-08

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Fudan University

Phase 2 Recruiting
160 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡